Copyright
©The Author(s) 2016.
World J Gastroenterol. Feb 7, 2016; 22(5): 1826-1833
Published online Feb 7, 2016. doi: 10.3748/wjg.v22.i5.1826
Published online Feb 7, 2016. doi: 10.3748/wjg.v22.i5.1826
Figure 1 Changes of factors in the experiment, model and control groups.
A, B: CD4+CD25+ Tregs were detected in rat peripheral blood mononuclear cells by flow cytometry. The proportions of CD4+CD25+ Tregs are shown; C: Serum levels of IL-10, TGF-β1 and IL-17A; D: Foxp3 protein expression in colon tissues; GAPDH was used as an internal control. Each group had five rats and the pictures shown were representative of three independent experiments. IL: Interleukin; TGF: Transforming growth factor.
Figure 2 Immunohistochemistry staining results in colon tissues from different groups.
IL: Interleukin; TGF: Transforming growth factor.
- Citation: Liu WX, Wang Y, Sang LX, Zhang S, Wang T, Zhou F, Gu SZ. Chymase inhibitor TY-51469 in therapy of inflammatory bowel disease. World J Gastroenterol 2016; 22(5): 1826-1833
- URL: https://www.wjgnet.com/1007-9327/full/v22/i5/1826.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i5.1826